WellTheory today announced the close of $5 million in new funding and the successful rollout of its proprietary AI tools, Care Hub and Care Scribe, across its care operations. New investors Samsung Next, Opal Ventures, and Up2 Fund joined the round, with continued support from existing investors Accel, OVO Fund, and BoxGroup.

WellTheory is a virtual care platform reversing the autoimmune epidemic by filling the gaps left behind in traditional healthcare. WellTheory offers a research-backed proprietary program that addresses the root cause of autoimmunity and treats the whole person with the aim to reduce symptoms, improve quality of life, and lower costs. WellTheory's platform centers around evidence-based, high-touch care led by an interdisciplinary team of autoimmune experts, including licensed registered dietitians and board-certified health coaches. It's an anti-symptom-masking model that goes beyond the pill, built by autoimmune patients and validated by decades of clinical research.